Pacifico Biolabs
Pacifico Biolabs uses mycelium fermentation biotechnology to produce Viando, a whole-muscle meat alternative designed to mimic the texture and nutritional profile of animal proteins. The company's first product is a chicken replacement with 30% protein content, with pork and fish alternatives currently in development. They target B2B customers including food manufacturers, foodservice chains, and meat processors looking for clean-label, sustainable ingredients.
Visit websiteBerlin, Germany
Foodtech
Biotechnology
Climate Tech
Funding summary
- Total raised
- €10.1M
- Funding rounds
- 2
Investors in Pacifico Biolabs
Investors on record for Pacifico Biolabs. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Pacifico Biolabs?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors